SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-21-011411
Filing Date
2021-11-22
Accepted
2021-11-22 16:48:23
Documents
78
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_033121.htm   iXBRL 10-Q 1738166
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 10316
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 10334
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 4576
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 5087
  Complete submission text file 0001387131-21-011411.txt   8150283

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE admp-20210331.xsd EX-101.SCH 49530
7 XBRL CALCULATION FILE admp-20210331_cal.xml EX-101.CAL 76761
8 XBRL DEFINITION FILE admp-20210331_def.xml EX-101.DEF 221502
9 XBRL LABEL FILE admp-20210331_lab.xml EX-101.LAB 406929
10 XBRL PRESENTATION FILE admp-20210331_pre.xml EX-101.PRE 334562
11 EXTRACTED XBRL INSTANCE DOCUMENT admp-10q_033121_htm.xml XML 1622332
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 211433215
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences